Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk

Abstract

The timing of puberty is a highly polygenic childhood trait that is epidemiologically associated with various adult diseases. Using 1000 Genomes Project–imputed genotype data in up to 370,000 women, we identify 389 independent signals (P < 5 × 10−8) for age at menarche, a milestone in female pubertal development. In Icelandic data, these signals explain 7.4% of the population variance in age at menarche, corresponding to 25% of the estimated heritability. We implicate 250 genes via coding variation or associated expression, demonstrating significant enrichment in neural tissues. Rare variants near the imprinted genes MKRN3 and DLK1 were identified, exhibiting large effects when paternally inherited. Mendelian randomization analyses suggest causal inverse associations, independent of body mass index (BMI), between puberty timing and risks for breast and endometrial cancers in women and prostate cancer in men. In aggregate, our findings highlight the complexity of the genetic regulation of puberty timing and support causal links with cancer susceptibility.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: GTEx tissue enrichment using LD score regression.
Figure 2: Stronger effects of AAM-associated signals on early menarche than late menarche in women.
Figure 3: Effects and 95% confidence intervals of genetically predicted AAM on risks for various sex-steroid-sensitive cancers, adjusted for the effects of the same AAM variants on BMI.

Similar content being viewed by others

Accession codes

Accessions

Gene Expression Omnibus

References

  1. Parent, A.S. et al. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr. Rev. 24, 668–693 (2003).

    Article  PubMed  Google Scholar 

  2. Perry, J.R., Murray, A., Day, F.R. & Ong, K.K. Molecular insights into the aetiology of female reproductive ageing. Nat. Rev. Endocrinol. 11, 725–734 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Perry, J.R. et al. Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature 514, 92–97 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Lunetta, K.L. et al. Rare coding variants and X-linked loci associated with age at menarche. Nat. Commun. 6, 7756 (2015).

    Article  CAS  PubMed  Google Scholar 

  5. Day, F.R. et al. Shared genetic aetiology of puberty timing between sexes and with health-related outcomes. Nat. Commun. 6, 8842 (2015).

    Article  CAS  PubMed  Google Scholar 

  6. Westra, H.J. et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 45, 1238–1243 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481–487 (2016).

    Article  CAS  PubMed  Google Scholar 

  8. Finucane, H.K. et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Preprint at bioRxiv https://dx.doi.org/10.1101/103069 (2017).

  9. Rao, S.S. et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159, 1665–1680 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Smemo, S. et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507, 371–375 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Mbarek, H. et al. Identification of common genetic variants influencing spontaneous dizygotic twinning and female fertility. Am. J. Hum. Genet. 98, 898–908 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Ong, K.K. et al. Genetic variation in LIN28B is associated with the timing of puberty. Nat. Genet. 41, 729–733 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Perry, J.R. et al. Meta-analysis of genome-wide association data identifies two loci influencing age at menarche. Nat. Genet. 41, 648–650 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zhang, J. et al. LIN28 regulates stem cell metabolism and conversion to primed pluripotency. Cell Stem Cell 19, 66–80 (2016).

    Article  CAS  PubMed  Google Scholar 

  15. Zhu, H. et al. Lin28a transgenic mice manifest size and puberty phenotypes identified in human genetic association studies. Nat. Genet. 42, 626–630 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Zhu, H. et al. The Lin28/let-7 axis regulates glucose metabolism. Cell 147, 81–94 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Baran, Y. et al. The landscape of genomic imprinting across diverse adult human tissues. Genome Res. 25, 927–936 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. van den Berg, S.M. & Boomsma, D.I. The familial clustering of age at menarche in extended twin families. Behav. Genet. 37, 661–667 (2007).

    Article  PubMed  Google Scholar 

  19. Ahlgren, M., Melbye, M., Wohlfahrt, J. & Sørensen, T.I. Growth patterns and the risk of breast cancer in women. N. Engl. J. Med. 351, 1619–1626 (2004).

    Article  CAS  PubMed  Google Scholar 

  20. Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol. 13, 1141–1151 (2012).

  21. Bhaskaran, K. et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet 384, 755–765 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  22. Locke, A.E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197–206 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Gao, C. et al. Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer. Int. J. Epidemiol. 45, 896–908 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  24. Guo, Y. et al. Genetically predicted body mass index and breast cancer risk: Mendelian randomization analyses of data from 145,000 women of European descent. PLoS Med. 13, e1002105 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  25. Abreu, A.P. et al. Central precocious puberty caused by mutations in the imprinted gene MKRN3. N. Engl. J. Med. 368, 2467–2475 (2013).

    Article  CAS  PubMed  Google Scholar 

  26. da Rocha, S.T., Edwards, C.A., Ito, M., Ogata, T. & Ferguson-Smith, A.C. Genomic imprinting at the mammalian Dlk1Dio3 domain. Trends Genet. 24, 306–316 (2008).

    Article  PubMed  Google Scholar 

  27. Giles, G.G. et al. Early growth, adult body size and prostate cancer risk. Int. J. Cancer 103, 241–245 (2003).

    Article  CAS  PubMed  Google Scholar 

  28. de Vries, L., Kauschansky, A., Shohat, M. & Phillip, M. Familial central precocious puberty suggests autosomal dominant inheritance. J. Clin. Endocrinol. Metab. 89, 1794–1800 (2004).

    Article  CAS  PubMed  Google Scholar 

  29. Wehkalampi, K., Widén, E., Laine, T., Palotie, A. & Dunkel, L. Patterns of inheritance of constitutional delay of growth and puberty in families of adolescent girls and boys referred to specialist pediatric care. J. Clin. Endocrinol. Metab. 93, 723–728 (2008).

    Article  CAS  PubMed  Google Scholar 

  30. Winkler, T.W. et al. Quality control and conduct of genome-wide association meta-analyses. Nat. Protoc. 9, 1192–1212 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  31. Willer, C.J., Li, Y. & Abecasis, G.R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Sudlow, C. et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  33. Day, F.R., Elks, C.E., Murray, A., Ong, K.K. & Perry, J.R. Puberty timing associated with diabetes, cardiovascular disease and also diverse health outcomes in men and women: the UK Biobank study. Sci. Rep. 5, 11208 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  34. Bulik-Sullivan, B.K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Loh, P.R. et al. Efficient Bayesian mixed-model analysis increases association power in large cohorts. Nat. Genet. 47, 284–290 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512–525 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  38. Segrè, A.V., Groop, L., Mootha, V.K., Daly, M.J. & Altshuler, D. Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet. 6, e1001058 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  39. Finucane, H.K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228–1235 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Gamazon, E.R. et al. A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 47, 1091–1098 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580–585 (2013).

  42. Sarkar, A., Ward, L.D. & Kellis, M. Functional enrichments of disease variants across thousands of independent loci in eight diseases. Preprint at bioRxiv http://dx.doi.org/10.1101/048066 (2016).

  43. Ernst, J. et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473, 43–49 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This research has been conducted using the UK Biobank Resource under applications 5122 and 9797. Full study-specific acknowledgments can be found in the Supplementary Note.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

All authors reviewed the original and revised manuscripts. Statistical analysis: F.R.D., D.J.T., H.H., D.I.C., H.F., P.S., K.S.R., S.W., A.K.S., E. Albrecht, E. Altmaier, M.A., C.M.B., T. Boutin, A. Campbell, E.D., A.G., C. He, J.J.H., R.K., I.K., P.-R.L., K.L.L., M.M., B.M., G.M., S.E.M., I.M.N., R.N., T.N., L.P., N. Perjakova, E.P., L.M.R., K.E.S., A.V. Segrè, A.V. Smith, L.S., A.T., J.R.B.P. Sample collection, genotyping and phenotyping: I.L.A., S. Bandinelli, M.W.B., J.B., S. Bergmann, M.B., E.B., S.E.B., M.K.B., J.S.B., H. Brauch, H. Brenner, L.B., T. Brüning, J.E.B., H.C., E.C., S.C., G.C.-T., T.C., F.J.C., D.L.C., A. Cox, L.C., K.C., G.D.S., E.J.C.N.d., R.d., I.D.V., J.D., P.D., I.d.-S.-S., A.M.D., J.G.E., P.A.F., L.F.-R., L. Ferrucci, D.F.-J., L. Franke, M.G., I.G., G.G.G., H.G., D.F.G., P.G., P.H., E.H., U.H., T.B.H., C.A.H., G.H., M.J.H., J.L.H., F.H., D.J.H., H.K.I., M.-R.J., P.K.J., D.K., Z.K., G.L., D.L., C.L., L.J.L., J.S.E.L., S. Lenarduzzi, J. Li, P.A.L., S. Lindstrom, Y.L., J. Luan, R.M., A. Mannermaa, H.M., M.I.M., C. Meisinger, T.M., C. Menni, A. Metspalu, K.M., L.M., R.L.M., G.W.M., A.M.M., M.A.N., P.N., H.N., D.R.N., A.J.O., T.A.O., S.P., A. Palotie, N. Pedersen, A. Peters, J.P., P.D.P.P., A. Pouta, P.R., I. Rahman, S.M.R., A.R., F.R.R., I. Rudan, R.R., D.R., C.F.S., M.K.S., R.A.S., M. Shah, R.S., M.C.S., U.S., M. Stampfer, M. Steri, K. Strauch, T. Tanaka, E.T., N.J.T., M.T., T. Truong, J.P.T., A.G.U., D.R.V.E., V.V., U.V., P.V., Q.W., E.W., K.W.v.D., G.W., R.W., B.H.R.W., J.H.Z., M. Zoledziewska, M. Zygmunt. Individual study principal investigators: B.Z.A., D.I.B., M.C., F.C., T.E., N.F., C.G., V.G., C. Hayward, P.K., D.A.L., P.K.E.M., N.G.M., D.O.M.-K., E.A.N., O.P., D.P., A.L.P., P.M.R., H.S., T.D.S., D.S., D.T., S.U., J.A.V., H.V., N.J.W., J.F.W., A.B.S., U.T., K.S.P., D.F.E., J.Y.T., J.C.-C., D.H., A. Murray, J.M.M., K. Stefansson, K.K.O., J.R.B.P. Working group: F.R.D., D.J.T., H.H., D.I.C., H.F., P.S., K.S.R., S.W., A.K.S., A.B.S., U.T., K.S.P., D.F.E., J.Y.T., J.C., D.H., A. Murray, J.M.M., K. Stefansson, K.K.O., J.R.B.P.

Corresponding authors

Correspondence to Ken K Ong or John R B Perry.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Additional information

A full list of members and affiliations appears in the Supplementary Note.

A full list of members and affiliations appears in the Supplementary Note.

A full list of members and affiliations appears in the Supplementary Note.

A full list of members and affiliations appears in the Supplementary Note.

A full list of members and affiliations appears in the Supplementary Note.

A full list of members and affiliations appears in the Supplementary Note.

Integrated supplementary information

Supplementary Figure 1 Manhattan plot displaying the genomic locations of the 389 genome-wide significant loci.

Previously identified genome-wide significant loci are shown in gold, and new loci are shown in purple. SNPs within 300 kb of the lead SNP at each locus are highlighted. The y axis has been truncated above 30.

Supplementary Figure 2 Number of genome-wide significant menarche loci per chromosome by chromosome size.

The X chromosome is highlighted in red.

Supplementary Figure 3 Quantile–quantile plot of heterogeneity P values between maternal and paternal parent-of-origin association testing for all 389 index variants.

Supplementary Figure 4 LocusZoom plots of menarche-associated variants at the MKRN3 locus (hg38) in the deCODE study, Iceland.

The 5′ UTR variant rs530324840 at position chr15:23565461 is labeled as a diamond and shown in purple; other variants are colored according to correlation (r2) with rs530324840 (see legends). –log10 P values are shown along the left y axis, and the right y axis corresponds to recombination rate, plotted as a solid gray line. (a) Associations under the paternal model, where the signal near 24 Mb corresponds to the common reported variant rs12148769. (b) Associations under the maternal model. (c) Associations under the additive model.

Supplementary Figure 5 LocusZoom plots of menarche-associated variants at the DLK1 locus (hg38) in the deCODE study, Iceland.

The variant rs138827001 at position chr14:100771634 is labeled as a diamond and shown in purple; other variants are colored according to correlation (r2) with rs138827001 (see legends). –log10 P values are shown along the left y axis, and the right y axis corresponds to recombination rate, plotted as a solid gray line. (a) Associations under the paternal model. (b) Associations under the maternal model. (c) Associations under the additive model.

Supplementary Figure 6 Association of menarche-associated variants with adult body mass index.

The blue bars (and left y axis) indicate the collective variance explained in adult BMI (with bootstrap-generated 95% CIs) by index menarche-associated SNPs grouped by their individual associations with BMI (in UK Biobank using an additive model controlling for chip and principal components). The red line (and right y axis) indicates the –log10 P value for the collective association with BMI of each group of SNPs. Purple squares correspond to collective associations with BMI at P < 0.05.

Supplementary Figure 7 Dose-response plots for Mendelian randomization analyses.

(ad) The individual effects on AAM of the 314 ‘BMI-unrelated’ autosomal AAM variants are plotted against risks for breast (a), prostate (b), endometrial (c) and ovarian (d) cancer. Red line, IVW regression; blue line, MR-Egger regression. MR-Egger supports the protective effect of later age at puberty on breast, prostate and endometrial cancers, but indicates pleiotropy in the association with ovarian cancer.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–7 and Supplementary Note (PDF 2390 kb)

Supplementary Tables

Supplementary Tables 1–16 (XLSX 5253 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Day, F., Thompson, D., Helgason, H. et al. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat Genet 49, 834–841 (2017). https://doi.org/10.1038/ng.3841

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.3841

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer